GT-TsF and Antigen Presentation.
Exponentially growing A20-2J cells were harvested from DMEM supplemented with 10% FCS and washed twice with HBSS. To prohibit A20-2J cell division, 107 cells were treated with 3.7 × 10 -5 M mitomycin C in 1 ml DMEM at 37°C for 30 min. The cells were then washed three times in HBSS. Under these conditions, A20-2J cells showed no growth after 7 d of culture. Where indicated, mitomycin C-treated A20-2J cells were incubated with a 1:200 final dilution of anti-I-A a or anti-I-E d mAb for 20 min at 4°C, then washed three times with HBSS. 100 #g of GAT in 1 ml or a 1:200 final dilution of monoclonal GT-TsF1 (WFll.3A1) in 1 ml was incubated with 107 A20-2J cells in DMEM containing 10% FCS for 30 min at 37°C in a humidified atmosphere of 5% CO2 in air. Cells were washed three times with HBSS, counted, and added in numbers indicated to BALB/c spleen cultures.
Spleen Cell Culture and Hemolytic Plaque Assay. Single-cell suspensions of BALB/cCum (H-2 d) spleen cells were placed in modified Mishell-Dutton type culture conditions as described (15) . mAb, GT-TsF, or treated A20-2J cells were added at culture initiation in concentrations/numbers indicated in table legends. Cultures were harvested 5 d after initiation, cells washed three times in HBSS, and PFC responses were assayed using SRBC coupled with the crossreacting polymer GAT as previously described (18) . PFC responses from in vivo primed BALB/c and 4R mice (Table III) were determined 7 d after GTMBSA immunization.
Results

Role of l-E Gene Products on GT-TsF1 Suppression. GT-TsF1 suppresses the
GTMBSA PFC responses of several inbred mouse strains, although no correlation between suppression and a particular allele within H-2 has been shown (11) . Table I summarizes the suppression patterns for five different H-2 haplotypes.
H-2 a""ak mice are suppressed by GT injection, and produce and are suppressed by GT-TsF1. H-2 b mice produce GT-TsF1, but are not suppressed by GT preimmunization or GT-TsF1. Conversely, H-2 a mice are suppressed by GT- This table summarizes previously published data (11, 12, 26, 27) . (), silent alleles.
TsF1, although they lack the ability to produce this factor. H-2 axb hybrid mice are suppressed by GT preimmunization, and produce and are suppressed by GTTsF1. GTMBSA responses of H-2 q cannot be suppressed. Although this is a limited sampling, it is striking that mice expressing I-E molecules (H-2 a'u'k and H-2 "xb) are suppressed by GT-TsF1 and those not expressing surface I-E molecules (H-2 b'q) are not suppressed. H-2 s haplotype mice do not express I-E molecules (19) . However, GT injection markedly diminishes the GTMBSA responses of SJL, A.SW, and B10.S mice (20, 21) . The protocol of GT injection followed by GTMBSA immunization measures tolerance-type induction and does not address the role of suppressor factors. Are H-2 ~ mice suppressed by GT-TsFI? Table II shows that neither SJL nor A.SW mice are suppressed by BALB/c GT-TsF1 (Exp. 1) and that SJL is not suppressed by B10.BR GT-TsF1 (Exp. 2). Therefore, it appears that H-2 s mice are not susceptible to GT-TsFl-mediated suppression. GT injection may induce tolerance rather than suppression in H-2 ~ mice. H-2 b mice express I-A b but not I-E, B10.A(3R) and B10.A(5R) mice express both I-A b and I-E k (19) . Table II , Exp. 3, shows that 5R mice are readily suppressed by GT-TsF1. Although not shown, 3R mice show a similar result. I-A b has no adverse affect on GT-TsF 1 susceptibility and, again, we see concordance of I-E expression and GT-TsF1 suppression.
Is the I-E requirement qualitative or quantitative? A.TFR5 (H-2 apS, E~, E~) mice express membrane I-E at low density levels, 80+% less than "normal" mice (22) . This is most likely due to the fact that E~ is not expressed, although E~ is expressed (22) . (A.TRF5 × D2.GD)F1 hybrid mice express I-E surface molecules. Does this correlate with GT-specific suppression? The GTMBSA PFC responses of (A.TRF5 x D2.GD)F1 hybrids are suppressed by GT preimmunization, by B6 (I-J b) GT-TsF1, BALB/c (I-J d) GT-TsF1, and B10.BR (I-J k) GT-TsF1 (Table  III) . In contrast, parental strains D2.GD and A.TFR5 are not suppressed by GT or GT-TsF1 injection. These data suggest that GT-TsF1 suppression requires expression of an Ee gene product and/or that the density of I-E expression is important.
1-E RECOGNITION BY I-J MOLECULES
Suppressor Defect in BIO.A(4R)
Mice. Araneo and Kapp (23) showed suppression of T cell proliferative responses to GTMBSA by GT-TsF. With one notable exception, their proliferation data are concordant with our PFC data. Araneo and Kapp (23) suppressed proliferative responses of B10.A(4R) to GTMBSA using GT-TsF 1. T cell proliferative, delayed hypersensitivity, and PFC responses are not always concordant, indicating the assay of different cell populations (24, 25) . Can GTMBSA PFC responses of 4R mice be suppressed? Table IV indicates that neither GT nor BALB/c (I-J d) GT-TsFs injection is inhibitory to subsequent * BALB/c and 4R mice were either injected with 0.5 ml BALB/c GT-TsF1 intravenously diluted 1:5 in HBSS (1.2 x 107 cell equivalents), injected intraperitoneally with 100 tLg GT in Maalox, or were uninjected. * 3 d after GT or BALB/c GT-TsF1 injection, the mice were immunized intraperitoneally with 20 t~g GT as GTMBSA in Maalox-pertussis as adjuvant. 7 d after GTMBSA immunization (day I 0) GT-specific PFC per spleen were enumerated. Numbers represent the arithmetic mean + standard error of the mean. Underlining indicates suppression. The F-distribution statistic was used to test significance in analysis of variance (ANOVA) between experimental groups.
Effect of GT-TsF1 or GT on the GTMBSA PFC Responses of BALB/c and 4R Mice
GTMBSA immunization. As control, the GTMBSA PFC responses of GT or GT-TsF1 injected mice are suppressed by >70%. Previously, we showed that H-2 b mice produce GT-TsF1 upon GT injection, however they are unable to make second-order Ts (Ts2). Do 4R mice display a similar defect? GTMBSA PFC responses of H-2 b mice are suppressed by factors that circumvent Ts2 (26, 27) . Hence, H-2 b mice are suppressed by monoclonal I-J ~ GT-TsF2 and I-J k GT-TsF3, but not by monoclonal I-J k GT-TsF1. To ascertain the cellular defect, monoclonal TsF were injected into 4R mice. Neither GT-TsF1 nor GT-TsF2 suppresses GTMBSA PFC responses of 4R spleen cell cultures, although these factors specifically suppress BALB/c spleen cell cultures (Table V) . Monoclonal GT-TsF3 suppresses the 4R GTMBSA PFC response, which suggests that 4R mice have a Ts3 defect. * Supernatants, each containing a different I-J k GT-specific suppressor factor, were added at 1:400 final dilution at culture initiation. All Mishell-Dutton cultures contained 2.5 gg GT as GTMBSA. * Nominal factor designation based upon kinetics of suppression (15) . 5 d after culture initiation, GT-specific responses were assayed. Underlining indicates suppression. Relationship of control GTMBSA culture (not receiving factor) to factor containing culture.
Demonstration of the Requirement for I-E Molecules Using mAbs.
Strains of mice not expressing I-E are not suppressed by GT-TsF 1 (Tables I-III and references  11, 26, 27) , implying, but not proving, that I-E expression is essential for factormediated suppression. This suggests that GT-TsF1 is presented by MHC class II-bearing cells and/or that GT-TsF1 recognizes (or is recognized in the context of) I-E molecules. To resolve these possibilities, we asked whether GT-TsF1 suppressive activity can be absorbed by normal spleen cells. Table VI shows that the suppressive activity of monoclonal GT-TsF1 (WF11.3A1) is absorbed by AKR/Cum spleen cells at 4 °C. If AKR/Cum (H-2 k) spleen cells are incubated with monoclonal anti-I-E k (17-3-3) at 4°C, before incubation with GT-TsF1, then they no longer absorb suppressor activity (Table VI) . Incubation of AKR/Cum spleen cells with a supernatant derived from the secretory P3X63Ag8 (P3) myeloma does not inhibit the ability of these cells to absorb GT-TsF1 activity. Although not shown, an immunoadsorbent column constructed with this same anti-I-E k mAb (17-3-3) does not bind I-J k GT-TsF1; therefore, the effect of 17-3-3 is directed not against the factor, but toward the target cell of the factor. Direct addition of anti-I-E k mAb (17-3-3) to AKR/Cum spleen cell cultures blocks GT-TsFl-mediated suppression (Table VII) . Addition of either 17-3-3 or Y-17 anti-I-E k mAb blocks suppression mediated by either I-J k GTTsF1 (WF1 1.3A1) or I-J d BALB/c GT-TsF1, while neither antibody adversely affects the GTMBSA PFC response of CBA]J (H-2 k) spleen cell cultures. These data lend support for the notion that anti-I-E k mAb blocks factor presentation and that the antibody is not directed against the factor.
Cellular Presentation of GT-TsF1. Our data implicate I-E, and hence APCs, in GT suppression. We would predict that I-E-bearing cells should function in a factor-presenting capacity. To test this hypothesis, we used the Ia-bearing BALB/c lymphoma cell line A20-2J. Between 102 tO 104 mitomycin C-treated A20-2J cells were added to BALB/c spleen cell Mishetl-Dutton cultures. Mito- mycin C blocked cellular division of the A20-2J cells. Addition of unpulsed A20-2J cells along with GTMBSA had no inhibitory effect upon the GT-specific PFC response of BALB/c spleen cells (Table VIII) . A20-2J cells were incubated with monoclonal GT-TsF1 (WF11.3A1) for 15 min at 4°C, washed four times, then added to BALB/c spleen cell cultures. Table VIII shows that 104 or 103 factorpulsed spleen cells suppress the GTMBSA response. 102 to 104 GAT-pulsed A20-2J present GAT to BALB/c spleen cell cultures.
Blocking of Factor Presentation by mAbs. The involvement of I-E molecules in
factor presentation is demonstrated by the blocking of A20-2J factor presentation by mAb. Direct addition ofGT-TsF 1 (WF 11.3A 1) to BALB/c spleen cells inhibits the GTMBSA response (Table IX) . Unpulsed A20-2J cells are not inhibitory. WF11.3Al-pulsed A20-2J cells inhibit the GT-specific PFC response. Incubation with anti-I-E d mAb before factor pulsing blocks the ability of A20-2J cells to present GT-TsF 1. The blocking of A20-2J factor presentation by anti-I-E d mAb is most likely not due to steric hinderance, as anti-I-A ~ does not block factor presentation. Conversely, anti-I-A ~, but not anti-I-E ~, mAb blocks GAT presentation by A20-2J. This serves as a negative control for anti-I-E d mAb and a positive control for anti-I-A d. Although not shown, mAb treatment of unpulsed A20-2J cells has no inhibitory effect upon the GTMBSA responses of BALB/c * Monoclonal I-J k GT-TsF1 (WF11.3A1) containing culture supernatants or a BALB/c spleen cell extract containing I-J d GT-TsF1 (6 × 108 ceil equivalents/ml) were added at 1:400 final concentration at culture initiation. * 10 t*l undiluted culture supernatants containing anti-I-E k mAb were added at culture initiation.
At initiation, cultures received 1.25 #g GT as GTMBSA. ' After 5 d of culture, GT-specific responses were assayed. Underlining indicates suppression. 
TABLE VIII
Factor and GAT Presentation by A20-2J Cells in BALB/c Spleen Cell Cultures
Blocking of A20-2J Factor Presentation by Anti-I-E k mAb
Mitomycin C, A20-2J cells* Direct addition to culture Antigen-specific PFC per Antibody blockFactor or antigen Factor* Antige nl culture! ing pulsing
* 10 s mitomycin C-treated A20-2J cells were added to indicated cultures. Surface/-region molecules were blocked with anti-l-E La (14-4-4S) or anti-l-A p'a (6.5.2) mAb as indicated above and described in the Materials and Methods. (Un)blocked A20-2J cells were pulsed with either monoclonal I-J ~ GT-TsF1 (WF11.3A1), GAT, or unpulsed as indicated and added at culture initiation. * As indicated, monoclonal I-J k GT-TsF1 (WF11.3A1) was added directly to culture at 1:400 final concentration at culture initiation. 0 At initiation, 1.25 ~tg GT as GTMBSA, 5 ~tg GAT, or no antigen additions were made to cultures. ! After 5 d culture, GT-or GAT-specific responses were assayed. Underlining indicates suppression.
Discussion
GT is unique in that it fails to induce humoral or cell-mediated immune responses in most inbred strains of mice (24, 25) . GT injection of H-2 b'd'k haplotype mice results in the production of an I-J-bearing TsF (GT-TsF1) that suppresses GTMBSA responses of H-2 "'d'k haplotype mice. In the present study, we show that GT-TsF1 function is restricted by I-E molecule expression in the recipient strain. In contrast, I-E expression does not appear to influence GTTsF1 production; I-E-negative mice (e.g., H-2 b) can make GT-TsF1 (26, 27) . GT-TsF1 suppresses susceptible strains regardless of haplotype (e.g., I-J k, GTTsF1 suppresses H-2", I-J k, H-2 a, I-jd; and H-2 k, I-J k mice) so long as the recipient strain expresses I-E molecules. Those strains unable to express I-E molecules are not suppressed by GT-TsF1. Therefore, I-E expression by the recipient is required for factor-mediated suppression. This observation suggests a role for MHC class II molecules (e.g., I-E) and implies the role of class II-bearing cells or APCs in the presentation of factor. Indeed, we find an association between I-E molecules and GT-TsF 1 presentation. Normal spleen cells or the Ia + cell line, A20-2J, present GT-TsF! to normal syngeneic spleen cells in vitro. Factor presentation is specifically blocked by anti-I-E mAb. In contrast, anti-I-A, but not anti-I-E, mAb blocks presentation of the I-A-restricted antigen GAT by A20-2J cells. This reciprocal experiment serves as a control for both GT-TsF1 and GAT presentation, and rules out nonspecific steric hindrance by mAb as the reason for lack of factor presentation by I-E-blocked A20-2J cells. Although at this juncture it is impossible to establish that I-J + GT-TsF1 recognizes (or is recognized by) I-E molecules, our data point in this direction.
Araneo and Kapp (23) found no MHC restriction between donors and recipi-ents of GT-TsF in the suppression of T cell proliferative responses to GTMBSA. Our data are concordant with theirs with one notable exception and, therefore, we come to a different conclusion. Araneo and Kapp (23) showed the GT-specific T cell proliferative responses of GTMBSA-primed B10.A(4R) mice were suppressed by GT-TsF derived from H-2 a mice. We are unable to demonstrate suppression of the PFC responses of 4R mice either in vivo with H-2 a (I-J a) GTTsF1 (Table IV) or in vitro with I-J k GT-TsF1 (Table V) . This disparity between T cell proliferation and PFC data is probably best explained by the fact that each assay measures different cell populations. Recently, we have shown (24, 25) that T cell proliferative, delayed hypersensitivity and PFC responses are not always concordant, when assigning immune response (It) gene responder status in the GAT and GT copolymer system. 4R mice do not express I-E surface molecules and GT-TsF1 does not suppress their GTMBSA PFC response. This is not to say that 4R mice cannot be suppressed by any GT-specific factor. GT suppression results from a cascade of suppressive events involving several distinct suppressor cells and their factors (12) . Neither monoclonal GT-TsF 1 nor GT-TsF2 suppress 4R mice, indicating a lack of suitable cellular target for these factors. On the other hand, monoclonal GT-TsF3 suppresses the GTMBSA PFC responses of 4R mice (Table V) showing a functional target cell for TsF3. It is possible that the factor-containing extract used by Araneo and Kapp (23) may have contained sufficient GT-TsF3 to suppress the T cell proliferative responses of 4R mice.
In the present study, we find that GT-TsFI is restricted to recipients expressing I-E, and A.SW and SJL mice that do not express surface I-E (19), are not suppressed by GT-TsF1 (Table II) . 5R mice, unlike parental B10 mice, express I-E, and are suppressed by GT-TsF1. Possible interference in the suppressive process by I-A b is ruled out, because B6, B10, A.BY (nonsuppressible), and 5R (suppressible) mice all express I-A b. A.TFR5 mice, which express low levels of E~, are not suppressed by GT-TsF 1 (Table III) . This raises the exciting possibility that either the surface I-E requirement for GT-TsF 1 susceptibility is quantitative and A.TFR5 expresses too little, or that the I-E restriction requires expression of the E~ gene. Our laboratory is currently addressing this question. Indeed, ours is not the first laboratory to show the role of MHC class II molecules in suppressor systems. Dorf and co-workers (28, 29) showed the involvement of I-A-bearing APCs in Tsl and Ts3 induction. They suggest that the presence of I-A on cells responsible to Ts induction does not necessarily imply a direct involvement of I-A in the Ts induction process (30) . Further, they suggest that Ia antigens are somehow involved in the induction of I-J determinants. Nagy and colleagues (3 I) were the first to report a role for I-E in suppression of the T cell response, and that mouse strains expressing I-E k are nonresponders to lactate dehydrogenase B. Nonresponsiveness is mediated by E~-specific Ts (31) and an Ec-specific TsF (32) . Our present data using GT-TsF1 are consistent with the E~ restriction.
Originally, the I-J subregion was defined and mapped by Murphy et al. (5) to a segment of the 17th chromosome of the murine MHC between the I-A and I-E subregions. Steinmetz and co-workers (33, 34) found that this portion of the 17th chromosome contained <3.4 kb DNA available for the I-J subregion, which is generally considered insufficient to encode for a single molecule >_20 kDa.
Nevertheless, several laboratories have reported I-J heterogeneity and their selective expression on different cellular (sub)sets. Anti-I-J k mAb detects I-J epitopes which are selectively expressed by different monoclonal TsF and have been used to phenotypically distinguish Ts subsets (15, 35, 36) . Evidence for the expression of I-J expression by T cells other Ts has been reported. Tada and Hayakawa (10) showed that some Th cells express I-J determinants distinct from those found on Ts. Gershon et al. (37) described contrasuppressor T (Tcs) cells that are suppressor antagonists and express unique I-J determinants. Niederhuber et al. (38) , using alioantisera, found I-J determinants on APCs. Murphy et al. (4) , using alloantisera, showed I-J (J2) determinants expressed by macrophages to be distinct Ts I-J (J1) determinants. Likewise, Nakamura et al. (39) and Dorf and co-workers (40) have reported the requirement for I-J-bearing APCs in suppressor systems.
What is "I-J"? Tada (41) proposed that I-J molecules are self-recognition structures on T cells that recognize self MHC class II (i.e., I-E) molecules. Our data agree with this hypothesis. To a large extent much of the confusion surrounding I-J appears to be a matter of nomenclature. We propose that I-J [4] calls these J2 determinants) seen by the antetope. These anti-prototope antibodies should be reactive with class II MHC molecules found on B cells and macrophages. Moreover, we would predict that anti-idiotype antibodies directed against anti-I-J (anti-antetope) mAb should react with class II epitopes. Anti-idiotype antisera directed against either anti-I-J k (WF8.C12.8) or anti-I-J d (WF18.2B15) mAb bind B cells and macrophages (42) . This same anti-idiotype blocks GT-TsF1-mediated suppression, in a manner similar to that of the present report. Therefore, expression of I-J determinants on cells other than T cells would appear to be artifactual.
We conclude that I-J is not H-2 encoded, but H-2 (e.g., I-E) influenced. Lack of sufficient DNA in the interval between Ea to E, to account for a separate definable I-J locus (33, 34) would not be a problem in that I-J is not H-2 encoded. In fact, the MHC influences expression of several non-MHC genes (43) . The MHC may influence the selective expression of non-MHC I-J genes, thus accounting for the apparent allelic nature of I-J. Still, several problems remain. First, how do B10.A(3R) and B10.A(5R) differ? Both appear to express identical I-E molecules in two-dimensional gels (44) . Small conformational differences of the translated E~ polypeptide chain could account for the difference in self-recognition repertoire between 3R and 5R, or alternatively there is strain-specific posttranslational modification of I-E molecules. Second, if I-J recognizes I-E, then how are I-J b molecules produced in H-2 b haplotypes, since H-2 b mice do not appear to express Ea surface molecules (44)? Possibly I-J b is complementary to LA b, or alternatively, a few, but sufficient, E~ cytoplasmic molecules are expressed on the surfaces of B cells and macrophages to allow the development of a I-J b T cell repertoire. This can be addressed with the B6.C bmlz (bm12) mutant mouse. This mutation affects the A~ locus and arose by gene conversion from the E~ locus (45) . If I-J b structures are complementary to I-A b molecules, then one would predict that the I-J b repertoire of H-2 bml2 bml2 would be different from parental H-2 b B6. Finally, why haven't I-J genes been identified? The mechanism for generating diversity of the antigen-recognition repertoire of immunoglobulins and T cell receptors results from gene rearrangement. It is this very rearrangement together with the expression on T cells, but not B cells, that allowed the identification of T cell receptor genes (46) . If, however, I-J molecules are genomically encoded and not rearranged and/or expressed by a very small subset of T cells, then our current technology may be unable to detect these genes.
Summary
Poly(GluS°Tyr 5°) (GT) is not immunogenic in most inbred mouse strains. GT injection produces an I-J-bearing, GT-specific T-cell-derived suppressor factor (GT-TsF1) in H-2 TM haplotype mice. GT-TsF1 generates second-order suppressor T cells (Ts2) in H-2 ~'a'k haplotype mice. Here, we show that in order for GT-TsF 1 to act, the recipient strain must express I-E molecules. This suggests that T cells are not the primary target of GT-TsF 1. GT-TsF 1 can be presented by Ia + A20-2J B lymphoma cells. GT-TsF1 presentation is blocked by anti-I-E, but not by anti-I-A, mAb, whereas GAT presentation is blocked by anti-I-A, but not by anti-I-E, mAbs. These data suggest that I-J recognizes (or is recognized by) I-E. The existence and role of I-J molecules in immune regulation are discussed in light of these data. 17 December 1985. 
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